| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-26 19:04 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
208,300 | |
| Filed 2025-11-26 19:03 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
40,000 | |
| Filed 2025-11-26 19:02 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
40,000 | |
| Filed 2025-11-26 19:02 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
70,000 | |
| Filed 2025-11-26 19:00 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
312,300 | |
| Filed 2025-11-26 19:00 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
550,000 | |
| Filed 2025-11-26 18:56 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
57 - Exercise of rights
|
-37,500 vol |
||
| Filed 2025-11-26 18:56 Tx date 2025-11-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
57 - Exercise of rights
|
-37,500 vol |
550,000 | |
| Filed 2025-11-07 17:52 Tx date 2025-11-05 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,475
-11,700 vol $1.75 each |
200,800 | |
| Filed 2025-11-07 15:56 Tx date 2025-10-30 |
$ONCO
Onco-Innovations Limited |
Rushton, Jared
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2025-10-24 08:51 Tx date 2025-10-23 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+37,700 vol |
37,700 | |
| Filed 2025-10-24 08:50 Tx date 2025-10-23 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-37,700 vol |
274,800 | |
| Filed 2025-10-15 19:52 Tx date 2025-10-14 |
$ONCO
Onco-Innovations Limited |
Gulka, Christopher David
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+40,000 vol |
40,000 | |
| Filed 2025-10-15 19:51 Tx date 2025-10-14 |
$ONCO
Onco-Innovations Limited |
Gulka, Christopher David
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-22 19:15 Tx date 2025-09-22 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-4,500 vol |
2,000 | |
| Filed 2025-09-22 19:15 Tx date 2025-09-19 |
$ONCO
Onco-Innovations Limited |
Stadnyk, Zachary Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
6,500 | |
| Filed 2025-09-19 18:10 Tx date 2025-09-19 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-9,050 vol |
2,250 | |
| Filed 2025-09-19 18:09 Tx date 2025-09-18 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
11,300 | |
| Filed 2025-09-19 00:03 Tx date 2025-09-16 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
13,800 | |
| Filed 2025-09-19 00:03 Tx date 2025-09-15 |
$ONCO
Onco-Innovations Limited |
Bensler, Graydon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
16,300 |